Outlook Therapeutics Inc (NASDAQ:OTLK)
| 0.22 Delayed Data As of Sep 26 |  +0.0067 / +3.14%Today’s Change | 0.20 Today|||52-Week Range 2.03 | -79.63% Year-to-Date |
Latest OTLK News | Press Releases
No recent news for Outlook Therapeutics Inc.
Today’s Trading
| Previous close | 0.21 |
| Today’s open | 0.22 |
| Day’s range | 0.21 - 0.22 |
| Volume | 4,058,099 |
| Average volume (3 months) | 4,532,494 |
| Market cap | $54.7M |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | +10.57% |
| Earnings growth (this year) | +29.44% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SLDBSolid Biosciences In... | -0.15 | -5.45% |
| ACETAdicet Bio Inc | +0.03 | +2.14% |
| DYAIDyadic International... | -0.18 | -8.65% |
| PSNLPersonalis Inc | 0.00 | 0.00% |
Data as of 3:59pm ET, 09/26/2023
Financials
| Next reporting date | December 21, 2023 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$66.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Iselin, New Jersey |
Forecasts
